Go to a specific date

Explore

The Public Inspection page
on FederalRegister.gov
offers a preview of documents scheduled to appear in the next day's
Federal Register issue. The Public Inspection page may also
include documents scheduled for later issues, at the request
of the issuing agency.

Document Details

The public meeting will be held February 16, 2007, from 12:30 p.m. to 4:30 p.m. in Atlanta, Georgia. Registration will begin at 11 a.m.

Document Type:

Notice

Document Citation:

72 FR 2698

Page:

2698-2699
(2 pages)

Document Number:

E7-794

Document Details

Enhanced Content - Table of Contents

This tables of contents is a navigational tool, processed from the
headings within the legal text of Federal Register documents.
This repetition of headings to form internal navigation links
has no substantive legal effect.

Enhanced Content - Sharing

Enhanced Content - Document Print View

Enhanced Content - Document Print View

Enhanced Content - Document Tools

These tools are designed to help you understand the official document
better and aid in comparing the online edition to the print edition.

These markup elements allow the user to see how the document follows the
Document Drafting Handbook
that agencies use to create their documents. These can be useful
for better understanding how a document is structured but
are not part of the published document itself.

Enhanced Content - Developer Tools

Official Content

Official Content

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Centers for Disease Control and Prevention, Department of Health and Human Services.

ACTION:

Notice of public meeting.

SUMMARY:

This notice announces a public meeting on the subject of tuberculosis detection in imported nonhuman primates. The purpose of the meeting is to review current Institute of Laboratory Animal Research recommendations and compare newer diagnostic tests available for tuberculosis testing in nonhuman primates.

DATES:

The public meeting will be held February 16, 2007, from 12:30 p.m. to 4:30 p.m. in Atlanta, Georgia. Registration will begin at 11 a.m.

ADDRESSES:

The public meeting will be held at the following location: Centers Start Printed Page 2699for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, Building 19 Auditorium A.

FOR FURTHER INFORMATION, CONTACT:

SUPPLEMENTARY INFORMATION:

Participation at the Public Meeting

Pre-registration is recommended. Because the meeting will be held at CDC's secure facility, non-U.S. citizens will be required to undergo a background check in order to attend. For individuals who are not U.S. citizens, the following information must be provided to the Zoonosis Team at least 15 days in advance:

Individual's Full Name (official):

Gender:

Date of Birth:

Place of Birth (city, province, state, country):

Country of Citizenship:

Passport Type and Number:

Date of Passport Issue:

Date of Passport Expiration:

Type of Visa and Expiration Date:

—If the visitor is a Permanent Resident of the U.S., provide Permanent Resident #

Visitor's Organization:

Visitor's Position/Title within the Organization:

Visitor's Organization Address:

Visitor's Organization Telephone Number:

Background

The presence of tuberculosis in nonhuman primates may pose a substantial health risk to caretakers and interfere with or interrupt research. Tuberculosis infections in nonhuman primates may have few outward symptoms, and testing of animals is usually needed to determine infection. Because of the public health risks associated with tuberculosis, nonhuman primates imported into the United States must be quarantined for a minimum of 31 days and have 3 negative tuberculosis skin tests performed at 2-week intervals in accordance with the Institute of Laboratory Animal Research (ILAR; formerly the Institute of Laboratory Animal Resources) guidelines that were published in 1980. The current accepted test for tuberculosis in nonhuman primates is the tuberculin skin test (TST) using Mammalian Old Tuberculin. The sensitivity and specificity of this test are not ideal. Since 1999, 1 to 54 cases of tuberculosis have been reported in imported nonhuman primates each year. In some cases, animals had multiple negative TSTs before a positive TST was noted. A few of the cases had negative TST results through the 31-day quarantine period and then had a positive TST after release from quarantine, thus jeopardizing research or colonies into which the animals were introduced.

Since the publication of the 1980 ILAR guidelines, several alternative diagnostic tests have been developed. The purpose of this meeting is to discuss available alternatives to the TST; compare test results with alternative tuberculosis detection methods; and generate interest in a formal review of new diagnostics for tuberculosis testing of nonhuman primates.

Public Meeting Procedures

The following procedures will be in place for this meeting:

1. Admission and participation in the public meeting are free. The meeting will be open to all persons.

2. Representatives from the CDC will conduct the public meeting. Experts on nonhuman primate importation, tuberculosis diagnostic testing in nonhuman primates, and ILAR guidelines will give presentations.

3. The public meeting is intended as a forum to share information and answer questions concerning tuberculosis testing in nonhuman primates.

4. All interested parties will have the opportunity to ask questions or make short comments regarding diagnostic tests for tuberculosis in nonhuman primates.

5. Statements made by CDC personnel and other federal personnel are intended to facilitate discussion of the issues or to clarify issues. Such statements should not be interpreted as providing legal, professional, or other advice.

6. The meeting is designed to share information and solicit individual views from the public. The meeting will not operate in consensus fashion. The meeting will be conducted in an informal and non-adversarial manner.

Start Signature

Dated: January 16, 2007.

James D. Seligman,

Chief Information Officer, Centers for Disease Control and Prevention.